Home › Kanser sa Dugo › Washington › Seattle

Pag-aaral pangklinika para sa Kanser sa Dugo sa Seattle, WA

Isang pag-aaral para sa Kanser sa Dugo ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Seattle. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects

Nagre-recruitObservasyonal na pag-aaral

Swedish Medical Center-Ballard Campus, Seattle
Swedish Medical Center-Cherry Hill, Seattle
Swedish Medical Center-First Hill, Seattle

Lahat ng edad · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT04242095

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo

Swedish Medical Center-Ballard Campus, Seattle
Swedish Medical Center-Cherry Hill, Seattle
Swedish Medical Center-First Hill, Seattle
at 1 pa

Edad 40 hanggang 75 · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT05334069

A Study to Investigate the Safety of Novel Dose Ramp-up Schedule(s) When Initiating Sonrotoclax in Participants Treated for Blood Cancers.

Nagre-recruitPhase 1/2

Fred Hutchinson Cancer Research Center, Seattle

Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT06697184

Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies

Nagre-recruitPhase 3

Fred Hutchinson Cancer Research Center, Seattle

Edad 18 pataas · Lahat ng kasarian · Na-update Set 21, 2026 · NCT07648264

Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia

Nagre-recruitPhase 1

University of Washington, Seattle

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 20, 2026 · NCT06001788

Mobile Health Application (PACT) to Improve Engagement in Advance Care Planning

Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo

Fred Hutch/University of Washington Cancer Consortium, Seattle

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 17, 2026 · NCT04515810

PUL-042 Treatment in Patients With Parainfluenza Virus (PIV), Human Metapneumovirus (hMPV) or Respiratory Syncytial Virus (RSV)

Nagre-recruitPhase 2

Fred Hutchinson Cancer Center, Seattle

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 4, 2026 · NCT06665100

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

Nagre-recruitObservasyonal na pag-aaral

Fred Hutchinson Cancer Research Center, Seattle

Lahat ng edad · Lahat ng kasarian · Na-update Hul 6, 2026 · NCT01351545

IVIG for Infection Prevention After CAR-T-Cell Therapy

Nagre-recruitPhase 2

Fred Hutch/University of Washington Cancer Consortium, Seattle

Edad 18 pataas · Lahat ng kasarian · Na-update Hun 29, 2026 · NCT05952804

211At-BC8-B10 Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory High-Risk Acute Leukemia or Myelodysplastic Syndrome

Nagre-recruitPhase 1/2

Fred Hutch/University of Washington Cancer Consortium, Seattle

Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Hun 22, 2026 · NCT03670966

Prospective Evaluation Of Delayed Effects Of Pediatric Car T Cell Therapy

Nagre-recruitObservasyonal na pag-aaral

Seattle Childrens Hospital, Seattle

Hanggang edad 30 · Lahat ng kasarian · Na-update Hun 18, 2026 · NCT06579469

Pharmacogenomics for Better Treatment of Fungal Infections Clinical Trial

Nagre-recruitPhase 2Malugod na tinatanggap ang malusog na boluntaryo

Fred Hutchinson Cancer Centre, Seattle

Edad 2 pataas · Lahat ng kasarian · Na-update Abr 16, 2026 · NCT06510699

CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)

Nagre-recruitPhase 1/2

University of Washington Medical Center, Seattle

Edad 18 pataas · Lahat ng kasarian · Na-update Abr 16, 2026 · NCT03328078

A Study for Participants Previously Treated With Century Therapeutics Cellular Therapy Product

Nagre-recruitObservasyonal na pag-aaral

Swedish Cancer Institute, Seattle

Edad 18 pataas · Lahat ng kasarian · Na-update Hun 25, 2025 · NCT05768269

PRO and Wearable Data Insights From Individuals With R/R Multiple Myeloma

Nagre-recruit

University of Washington, Seattle

Edad 18 pataas · Lahat ng kasarian · Na-update Abr 20, 2025 · NCT05956457

Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)

Nagre-recruitPhase 1

Fred Hutchinson Cancer Center, Seattle

Edad 18 pataas · Lahat ng kasarian · Na-update Abr 15, 2025 · NCT06462365

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

Nagre-recruitPhase 1

Seattle Children's Hospital, Seattle

Edad 1 hanggang 21 · Lahat ng kasarian · Na-update Dis 6, 2024 · NCT05476770

Study of VIP943 in Subjects With Advanced CD123+ Hematologic Malignancies

Nagre-recruitPhase 1

Fred Hutchinson Cancer Center, Seattle

Edad 18 pataas · Lahat ng kasarian · Na-update Nob 15, 2024 · NCT06034275

Pag-aaral para sa Kanser sa Dugo sa ibang lungsod

Iba pang pag-aaral sa Seattle

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.